
Sai Pharma Distributors Private Limited
Pharmaceutical trading company specializing in drugs and medicines.
Pharmaceutical trading company specializing in drugs and medicines.
Sai Pharma Distributors Private Limited (SPDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 March 2000 and has a history of 25 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹8.42 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Gudala, Amarnath Gudala, Krishna Gudala, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24239TG2000PTC034017
034017
Private Limited Indian Non-Government Company
24 Mar 2000
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arun Gudala ![]() | Director | 11-Aug-2012 | Current |
Amarnath Gudala ![]() | Director | 01-Feb-2008 | Current |
Krishna Gudala ![]() | Whole-Time Director | 24-Mar-2000 | Current |
Sampath Gudala ![]() | Whole-Time Director | 24-Mar-2000 | Current |
Renuka Gudala ![]() | Whole-Time Director | 24-Mar-2000 | Current |
Sai Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.69% increase. The company also saw a substantial improvement in profitability, with a 82.95% increase in profit. The company's net worth Soared by an impressive increase of 59%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Sai Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Arun Gudala, Amarnath Gudala and 3 more are mutual person
Arun Gudala and Krishna Gudala are mutual person
Amarnath Gudala is a mutual person
Krishna Gudala and Sampath Gudala are mutual person
₹8.42 Cr
₹1.70 Cr
Date | Lender | Amount | Status |
---|---|---|---|
09 May 2019 | Others | ₹7.44 Cr | Open |
21 Dec 2018 | Others | ₹7.50 M | Open |
08 Oct 2004 | Corporation Bank | ₹2.30 M | Open |
24 Apr 2015 | Corporation Bank | ₹1.70 Cr | Satisfied |
Sai Pharma Distributors has a workforce of 50 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sai Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Pharma Distributors's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sai Pharma Distributors Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Sai Pharma Distributors Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with Others of Rs. 7.44 Cr registered on 09 May 2019 with Charge ID 100268850 was modified on 28 Dec 2022.
A charge with Others of Rs. 0.75 Cr registered on 21 Dec 2018 with Charge ID 100227023 was modified on 28 Dec 2022.
A charge registered on 24 Apr 2015 via Charge ID 10567837 with Corporation Bank was fully satisfied on 10 Jul 2019.
A charge with Others amounted to Rs. 7.44 Cr with Charge ID 100268850 was registered on 09 May 2019.
Sai Pharma Distributors Private Limited was incorporated on 24 Mar 2000.
The authorized share capital of Sai Pharma Distributors Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 9.90 M.
Currently 5 directors are associated with Sai Pharma Distributors Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sai Pharma Distributors Private Limited is Shop.No.3-5-1093/22/A, Opposite Blood Bank Narayanguda India, Secunderabad, Telangana, 500029.
The corporate identification number (CIN) of Sai Pharma Distributors Private Limited is U24239TG2000PTC034017 and the company number is 034017 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Sai Pharma Distributors Private Limited has risen by 42.69%.
As Per 2023 financial reports, 50 employees are currently employed by Sai Pharma Distributors Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Sai Pharma Distributors Private Limited has experienced an upsurge of 59.00%.
As per the financial statements for fiscal Year 2023, The total open charges for Sai Pharma Distributors Private Limited amount to ₹ 8.42 Cr.
The most recent Balance Sheet for Sai Pharma Distributors Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
MP